Immune marker expression of irradiated mesothelioma cell lines

BACKGROUND: Though immune checkpoint inhibition has recently shown encouraging clinical efficacy in mesothelioma, most patients do not respond. Combining immune checkpoint inhibition with radiotherapy presents an attractive option for improving treatment responses owing to the various immunomodulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Faith, Keam, Synat, Hoang, Tracy Seymour, Creaney, Jenette, Gill, Suki, Nowak, Anna K., Ebert, Martin, Cook, Alistair M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659742/
https://www.ncbi.nlm.nih.gov/pubmed/36387076
http://dx.doi.org/10.3389/fonc.2022.1020493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659742/
https://www.ncbi.nlm.nih.gov/pubmed/36387076
http://dx.doi.org/10.3389/fonc.2022.1020493

Ejemplares similares